hematological agents	classified by	ATC
ATC	contains	hematological agents
hematological agents	include	anticoagulants
hematological agents	include	antiplatelets
hematological agents	include	hemostatic agents
hematological agents	include	thrombolytics
hematological agents	include	fibrinolytics
hematological agents	include	clotting factors
hematological agents	include	blood substitutes
hematological agents	include	iron chelators
hematological agents	include	erythropoiesis stimulants
hematological agents	include	platelet agonists
hematological agents	include	platelet inhibitors
hematological agents	include	coagulation inhibitors
anticoagulants	used for	stroke prevention
anticoagulants	used for	venous thromboembolism
anticoagulants	used for	atrial fibrillation
anticoagulants	include	warfarin
anticoagulants	include	heparin
anticoagulants	include	DOACs
DOACs	include	apixaban
DOACs	include	rivaroxaban
DOACs	include	dabigatran
DOACs	include	edoxaban
antiplatelets	used for	coronary artery disease
antiplatelets	used for	peripheral artery disease
antiplatelets	include	aspirin
antiplatelets	include	clopidogrel
antiplatelets	include	ticagrelor
antiplatelets	include	prasugrel
hemostatic agents	used for	bleeding disorders
hemostatic agents	include	tranexamic acid
hemostatic agents	include	aminocaproic acid
hemostatic agents	include	fibrinogen concentrate
thrombolytics	used for	myocardial infarction
thrombolytics	used for	ischemic stroke
thrombolytics	include	alteplase
thrombolytics	include	reteplase
thrombolytics	include	tenecteplase
fibrinolytics	used for	pulmonary embolism
fibrinolytics	include	urokinase
fibrinolytics	include	streptokinase
clotting factors	used for	hemophilia A
clotting factors	used for	hemophilia B
clotting factors	include	factor VIII
clotting factors	include	factor IX
clotting factors	include	factor VIIa
blood substitutes	used for	anemia
blood substitutes	include	hemoglobin-based oxygen carriers
blood substitutes	include	perfluorocarbon emulsions
iron chelators	used for	iron overload
iron chelators	include	deferoxamine
iron chelators	include	deferasirox
iron chelators	include	deferiprone
erythropoiesis stimulants	used for	chronic kidney disease
erythropoiesis stimulants	used for	chemotherapy-induced anemia
erythropoiesis stimulants	include	epoetin alfa
erythropoiesis stimulants	include	darbepoetin alfa
platelet agonists	used for	platelet function disorders
platelet agonists	include	ADP receptor agonists
platelet agonists	include	thromboxane analogs
platelet inhibitors	used for	platelet aggregation
platelet inhibitors	include	glycoprotein IIb/IIIa inhibitors
platelet inhibitors	include	GPIIb/IIIa antagonists
coagulation inhibitors	used for	factor Xa inhibition
coagulation inhibitors	include	rivaroxaban
coagulation inhibitors	include	apixaban
coagulation inhibitors	include	edoxaban
coagulation inhibitors	include	dabigatran
coagulation inhibitors	include	heparin
anticoagulants	contraindicated in	active bleeding
anticoagulants	contraindicated in	severe thrombocytopenia
antiplatelets	contraindicated in	platelet count <50,000
hemostatic agents	contraindicated in	active clotting
thrombolytics	contraindicated in	hemorrhagic stroke
thrombolytics	contraindicated in	recent major surgery
fibrinolytics	contraindicated in	uncontrolled hypertension
clotting factors	contraindicated in	uncontrolled bleeding
blood substitutes	contraindicated in	severe allergic reactions
iron chelators	contraindicated in	renal impairment
erythropoiesis stimulants	contraindicated in	uncontrolled hypertension
platelet agonists	contraindicated in	platelet dysfunction
platelet inhibitors	contraindicated in	active bleeding
coagulation inhibitors	contraindicated in	pregnancy
anticoagulants	monitored by	INR
anticoagulants	monitored by	aPTT
anticoagulants	monitored by	antiâ€‘Xa
antiplatelets	monitored by	platelet function tests
hemostatic agents	monitored by	bleeding time
thrombolytics	monitored by	neurological assessment
fibrinolytics	monitored by	clot lysis markers
clotting factors	monitored by	factor activity assays
blood substitutes	monitored by	oxygen delivery metrics
iron chelators	monitored by	ferritin levels
erythropoiesis stimulants	monitored by	hemoglobin levels
platelet agonists	monitored by	platelet aggregation studies
platelet inhibitors	monitored by	platelet aggregation studies
coagulation inhibitors	monitored by	coagulation assays
hematological agents	reduce	mortality in thrombotic events
hematological agents	improve	quality of life in bleeding disorders
